GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (FRA:BHM) » Definitions » Short Percentage of Float

Bachem Holding AG (FRA:BHM) Short Percentage of Float


View and export this data going back to 2023. Start your Free Trial

What is Bachem Holding AG Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Bachem Holding AG's Short Percentage of Float

For the Chemicals subindustry, Bachem Holding AG's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bachem Holding AG's Short Percentage of Float Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bachem Holding AG's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's Short Percentage of Float falls into.


Bachem Holding AG (FRA:BHM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (FRA:BHM) » Definitions » Short Percentage of Float
Comparable Companies
XSWX:DESN TSE:4063 SAU:2010 XTER:BAS DOW XKRX:051910 CE SHSE:600989 SZSE:002493 TSE:4091 XKRX:086520 XKLS:5183 TSE:3407 TPE:1326 SZSE:002460 XBRU:SYENS SHSE:600160 SHSE:603260 SHSE:600426 SZSE:000408
Traded in Other Exchanges
BANBz:UK BANB:Switzerland
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Website
https://www.bachem.com
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.